Identification and analysis of key genes related to efferocytosis in colorectal cancer
Authors:
Open Access
- 6 August 2024
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1-17
Abstract
The impact of efferocytosis-related genes (ERGs) on the diagnosis of colorectal cancer (CRC) remains unclear. In this study, efferocytosis-associated biomarkers for the diagnosis of CRC were identified by integrating data from transcriptome sequencing and public databases. Finally, the expression of biomarkers was validated by real-time quantitative polymerase chain reaction (RT-qPCR). Our study may provide a reference for CRC diagnosis. It has been shown that some efferocytosis related genes (ERGs) are associated with the development of cancer. However, it is still uncertain how ERGs may influence the diagnosis of colorectal cancer (CRC). In our study, the CRC cohorts were gained from transcriptome sequencing and the gene expression omnibus (GEO) database (GSE71187). Efferocytosis related biomarkers with diagnostic utility for CRC were identified through combining differentially expressed analysis, machine learning algorithms, and receiver operating characteristic (ROC) analysis. Then, infiltration abundance of immune cells between CRC and control was evaluated. The regulatory networks (including mRNA-miRNA-lncRNA and miRNA/transcription factors (TF)-mRNA networks) were created. Finally, the expression of biomarkers was validated via real-time quantitative polymerase chain reaction (RT-qPCR). There were 3 biomarkers (ELMO3, P2RY12, and PDK4) related diagnosis for CRC patients gained. ELMO3 was highly expressed in CRC group, while P2RY12 and PDK4 was lowly expressed. Besides, the infiltrating abundance of 3 immune cells between CRC and control groups was significantly differential, namely activated CD4 memory T cells, macrophages M0, and resting mast cells. We then constructed a mRNA-miRNA-lncRNA network containing 3 mRNAs, 33 miRNAs, and 22 lncRNAs, and a miRNA/TF-mRNA network including 3 mRNAs, 33 miRNAs, and 7 TFs. Additionally, RT-qPCR results revealed that the expression trends of all biomarkers were consistent with the transcriptome sequencing data and GSE71187. Taken together, this study provides three efferocytosis related biomarkers (ELMO3, P2RY12, and PDK4) for diagnosis of CRC, providing a scientific reference for further studies of CRC.Keywords
Funding Information
- The study was supported by Science and Technology Research Project of Guizhou Provincial Administration of Traditional Chinese Medicine (QZYY-2024-051, QZYY-2024-051)
This publication has 59 references indexed in Scilit:
- PPAR/PDK4 pathway is involved in the anticancer effects of cGMP in pancreatic cancerBiochemical and Biophysical Research Communications, 2023
- Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment optionsCancer Medicine, 2023
- RETRACTED ARTICLE: Molecular mechanism study and tumor heterogeneity of Chinese angelica and Fructus aurantii in the treatment of colorectal cancer through computational and molecular dynamicsFunctional & Integrative Genomics, 2023
- Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancerCellular Oncology, 2023
- Dioscin reduced chemoresistance for colon cancer and analysis of sensitizing targetsBiochemical and Biophysical Research Communications, 2022
- First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosisCell Metabolism, 2021
- The complex roles of efferocytosis in cancer development, metastasis, and treatmentBiomedicine & Pharmacotherapy, 2021
- ELMO3 – a Negative Prognostic Marker in Minor Salivary Gland CarcinomaPathology and Oncology Research, 2018
- Curcumin mediated down‐regulation of αVβ3 integrin and up‐regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cellsPhytotherapy Research, 2017
- ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short reportCellular Oncology, 2016